Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy

References

• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• TangDZhaoXYangTWangCPaclitaxel prodrug based mixed micelles for tumor-targeted chemotherapyRSC Adv201881380389
   Web of Science ®Google Scholar
• WangCChenSWangYLipase-Triggered Water-Responsive “Pandora’s Box” for Cancer Therapy: Toward Induced Neighboring Effect and Enhanced Drug PenetrationAdv Mater201830141706407
   Web of Science ®Google Scholar
• GuYLiJLiYNanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancerInt J Nanomedicine2016115757577027843316
   PubMed Web of Science ®Google Scholar
• RamasamyTHaidarZSTranTHLayer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugsActa Biomater201410125116512725169256
   PubMed Web of Science ®Google Scholar
• SundaramoorthyPRamasamyTMishraSKEngineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cellsActa Biomater20164222023127395829
   PubMed Web of Science ®Google Scholar
• RamasamyTRuttalaHBSundaramoorthyPMultimodal selenium nanoshell-capped Au@mSiO2 nanoplatform for NIR-responsive chemophotothermal therapy against metastatic breast cancerNPG Asia Mater2018104197216
   Google Scholar
• AbbadSWangCWaddadAYLvHZhouJPreparationZJPreparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrateInt J Nanomedicine20151030532025609946
   PubMed Web of Science ®Google Scholar
• Zununi VahedSSalehiRDavaranSSharifiSLiposome-based drug co-delivery systems in cancer cellsMater Sci Eng C Mater Biol Appl2017711327134127987688
   PubMed Web of Science ®Google Scholar
• WangCChenSYuQHuFYuanHTaking advantage of the disadvantage: employing the high aqueous instability of amorphous calcium carbonate to realize burst drug release within cancer cellsJ Mater Chem B201751120682073
   PubMed Web of Science ®Google Scholar
• LiMLiYHuangXLuXCaptopril-polyethyleneimine conjugate modified gold nanoparticles for co-delivery of drug and gene in anti-angiogenesis breast cancer therapyJ Biomater Sci Polym Ed2015261381382726166244
   PubMed Web of Science ®Google Scholar
• WanJWuWZhangRLiuSHuangYAnti-EGFR antibody conjugated silica nanoparticles as probes for lung cancer detectionExp Ther Med20171443407341229042926
   PubMed Web of Science ®Google Scholar
• ZhengTWangAHuDWangYTumor-targeting templated silica nanoparticles as a dual-drug delivery system for anti-angiogenic ovarian cancer therapyExp Ther Med20171432162217028962137
   PubMed Web of Science ®Google Scholar
• WuHZhaoYMuXA silica-polymer composite nano system for tumor-targeted imaging and p53 gene therapy of lung cancerJ Biomater Sci Polym Ed201526638440025624096
   PubMed Web of Science ®Google Scholar
• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• ChenYFuZXuSThe prognostic value of CD44 expression in gastric cancer: a meta-analysisBiomed Pharmacother201468669369725194445
   PubMed Web of Science ®Google Scholar
• BaoWFuH-JXieQ-SHER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer CellsGastroenterology20111416620762087
   Google Scholar
• Pályi-KrekkZBarokMIsolaJTammiMSzöllosiJNagyPHyaluronan-induced masking of ErbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancerEur J Cancer200743162423243317911008
   PubMed Web of Science ®Google Scholar
• YoonCParkDJSchmidtBCD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistanceClin Cancer Res201420153974398824947926
   PubMed Web of Science ®Google Scholar
• YangZLuoHCaoZDual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancerNanoscale2016822115431155827203688
   PubMed Web of Science ®Google Scholar
• PontaHShermanLHerrlichPACD44: from adhesion molecules to signalling regulatorsNat Rev Mol Cell Biol200341334512511867
   PubMed Web of Science ®Google Scholar
• LiRLiuTWangKHyaluronic modified and amine-functionalized silica nanoparticles as intracellular siRNA delivery carriers in lungCancer Gene Therapy2016961019110200
   Google Scholar
• LiRLiuTWangKHyaluronic acid-modified zirconium phosphate nanoparticles for potential lung cancer therapyBiomedizinische Technik Biomedical Engineering20166216773
   Web of Science ®Google Scholar
• WangZTianYZhangHUsing hyaluronic acid-functionalized pH stimuli-responsive mesoporous silica nanoparticles for targeted delivery to CD44-overexpressing cancer cellsInt J Nanomedicine2016116485649727980406
   PubMed Web of Science ®Google Scholar
• CorreiaALBissellMJThe tumor microenvironment is a dominant force in multidrug resistanceDrug Resist Updat2012151–2394922335920
   PubMed Web of Science ®Google Scholar
• HuKMiaoLGoodwinTJLiJLiuQHuangLQuercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of NanoparticlesACS Nano20171154916492528414916
   PubMed Web of Science ®Google Scholar
• TrédanOGalmariniCMPatelKTannockIFDrug resistance and the solid tumor microenvironmentJ Natl Cancer Inst200799191441145417895480
   PubMed Web of Science ®Google Scholar
• NiehrsCAcebronSPMitotic and mitogenic Wnt signallingEmbo J201231122705271322617425
   PubMed Web of Science ®Google Scholar
• SunYCampisiJHiganoCTreatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16BNat Med20121891359136822863786
   PubMed Web of Science ®Google Scholar
• MinaeiASabzichiMRamezaniFHamishehkarHSamadiNCo-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cellsMol Biol Rep20164329910526748999
   PubMed Web of Science ®Google Scholar
• RavishankarDRajoraAKGrecoFOsbornHMFlavonoids as prospective compounds for anti-cancer therapyInt J Biochem Cell Biol201345122821283124128857
   PubMed Web of Science ®Google Scholar
• ChakravartyGMathurAMalladePNelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cellsBiochimie2016124536426844637
   PubMed Web of Science ®Google Scholar
• WuHLiuSGongJVCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunctionCancer Lett2017393223228216375
   PubMed Web of Science ®Google Scholar
• ShiJSuYLiuWChangJZhangZA nanoliposome-based photoactivable drug delivery system for enhanced cancer therapy and overcoming treatment resistanceInt J Nanomedicine2017128257827529180864
   PubMed Web of Science ®Google Scholar
• ZhouYWangSYingXDoxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancerInt J Nanomedicine2017126153616828883726
   PubMed Web of Science ®Google Scholar
• WangCLiMYangTA self-assembled system for tumor-targeted co-delivery of drug and geneMater Sci Eng C Mater Biol Appl20155628028526249591
   PubMed Web of Science ®Google Scholar
• CondeJOlivaNZhangYArtziNLocal triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer modelNat Mater201615101128113827454043
   PubMed Web of Science ®Google Scholar
• JiangDWangMWangTZhangBLiuCZhangNMultifunctionalized polyethyleneimine-based nanocarriers for gene and chemotherapeutic drug combination therapy through one-step assembly strategyInt J Nanomedicine2017128681869829263663
   PubMed Web of Science ®Google Scholar
• WuCXuJHaoYApplication of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cellsInt J Nanomedicine2017127979799229184399
   PubMed Web of Science ®Google Scholar
• WangTYuXHanLLiuTLiuYZhangNTumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNAInt J Nanomedicine2017124773478828740384
   PubMed Web of Science ®Google Scholar
• RamasamyTRuttalaHBGuptaBSmart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive reviewJ Control Release201725822625328472638
   PubMed Web of Science ®Google Scholar
• RamasamyTRuttalaHBChitrapriyaNEngineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumorsActa Biomater20174813114327794477
   PubMed Web of Science ®Google Scholar
• WangCBaoXDingXA multifunctional self-dissociative polyethyleneimine derivative coating polymer for enhancing the gene transfection efficiency of DNA/polyethyleneimine polyplexes in vitro and in vivoPolym Chem201565780796
   Web of Science ®Google Scholar
• HeXWuXWangKShiBHaiLMethylene blue-encapsulated phosphonate-terminated silica nanoparticles for simultaneous in vivo imaging and photodynamic therapyBiomaterials200930295601560919595455
   PubMed Web of Science ®Google Scholar
• XiongHduSNiJZhouJYaoJMitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicinBiomaterials201694708327105438
   PubMed Web of Science ®Google Scholar
• ZhangZXuSWangYNear-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cellsJ Colloid Interface Sci2018509475728881205
   PubMed Web of Science ®Google Scholar
• YeMHanYTangJA Tumor-Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in CancersAdv Mater201729381702342
   Web of Science ®Google Scholar
• DingXXuXZhaoYTumor targeted nanostructured lipid carrier co-delivering paclitaxel and indocyanine green for laser triggered synergetic therapy of cancerRSC Adv20177563508635095
   Web of Science ®Google Scholar
• YangRMFuCPFangJZHyaluronan-modified superparamagnetic iron oxide nanoparticles for bimodal breast cancer imaging and photothermal therapyInt J Nanomedicine20171219720628096667
   PubMed Web of Science ®Google Scholar
• ZhouLShangYLiuCOverexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancerInt J Cancer2014135102329233724706505
   PubMed Web of Science ®Google Scholar
• WangXChenYDahmaniFZYinLZhouJYaoJAmphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxelBiomaterials201435267654766524927684
   PubMed Web of Science ®Google Scholar